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INTRODUCTION 
              
     
Hypertension is one of the most common diseases of mankind which results 
in a very high incidence of morbidity and mortality.  
Hypertension is the most important public problem of the modern world. It 
is one of the most common diseases which are easily detectable, effectively 
treatable and leading to fatal complication if left untreated.   
The understanding of the pathophysiology of the hypertension has widened, 
still about 90 to 95% of the causes do not have an identifiable cause and is known 
as primary or essential hypertension. 40, 42 In small group of hypertension 5 to 10% 
an etiology could be identified, this is the secondary hypertension. According to 
JNC 7, hypertension is said to be present when the systolic and diastolic blood 
pressure exceeds 140 and 90 mm Hg respectively.   
  Hypertension causes an increase in left ventricular mass resulting in 
increased stiffness of the left ventricle leads to reduced coronary reserve 
33,35,36,40,41
, silent myocardial ischemia, and abnormal electrophysiological property 
of hypertrophied myocyte and conduction disturbances.   
 
         These changes probably accounts for the increased morbidity and mortality 
associated with hypertensive heart disease. Hypertension is also associated with 
increased cerebrovascular accidents 31, 32.  
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         In the assessment of cardiac status in such patients ECG forms an important 
investigatory procedure and a very economical tool and easily applies to large 
number of population. Though normal ECG may be found in many cases of 
moderate to severe hypertension it still remains a useful means of diagnosis of 
hypertension associated with axis deviation, bundle branch block, fascicular block 
and myocardial infarction associated with hypertension 23,24,25,26.                                                                                             
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AIMS 
1) To study the incidence of conduction disturbances in patients with primary 
hypertension, 
2) To identify the most common type of conduction defect and incidence among 
males and females. 
 3) The identify the role of diastolic blood pressure that will affect the prevalence 
of conduction disturbances. 
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REVIEW OF LITERATURE 
ANATOMY OF THE CONDUCTION SYSTEM 
The components of the conduction system are  
a) S.A Node  
b) Preferential inter nodal pathway  
c) A.V Node  
d) Bundle of HIS 
e) Right bundle branch 
f) Left bundle  branch 
g) Left anterior fascicles 
h) Left posterior fascicle 
 
THE SINUS NODE (SINO-ATRIAL NODE) 
            S.A Node is the pacemaker of the heart. It is a small flattened ellipsoid 
strip of specialized muscle about 3mm width, 15mm long and 1mm thick. 
       It is situated in the wall of the right atrium near the upper end of the sulcus 
terminalis and extending over the front of the opening of superior vena cava. The 
fibers of SA Node are 3-5 microns in diameter. In contrast to the diameter of 15-
20 microns of the surrounding atrial muscle fibers. 
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INTERNODAL PATHWAY 
           These fibers connect SA Node to AV node through various pathways but 
most prominent are three pathways. These are as follows; 
          a) Anterior internodal tract of BACHMANN. 
          b) Middle internodal tract of WENCKEBACH. 
         c) Posterior internodal tract of THORAL. 
THE ANTERIOR INTERNODAL TRACT 
       It leaves the anterior margin of SA Node, passes anterior to the superior vena 
cava to enter the crest of the A V Node. 
 
THE MIDDLE INTERNODAL TRACT 
                Leaves the posterior margin of S.A node. passes posterior to the superior 
venacava, descends in the inter atrial septum and merges with the fibers of anterior 
internodal tract , to enter the crest of  A.V Node. 
 
THE POSTEROR INTERNODAL TRACT 
            It leaves the posterior margin of S.A Node, runs with the crista terminalis, 
curves through the valves of inferior venacava to enter the posterior margin of A.V 
Node. 
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THE ATRIO-VENTRICULAR NODE (A.V .NODE) 
          It is situated in the right atrial side of the interatrial septum just above the 
opening of the coronary sinus. 
 
BUNDAL OF HIS 
         It passes from the A.V Node in the membranous part of the interventricular 
septum and divides into the right and left bundle branch, on either side of the 
septum. 
 
RIGHT BUNDLE BRANCH 
        It travels down the septum to the anterior wall of the ventricle, enters the base 
of the anterior papillary muscle. 
 
LEFT BUNDLE BRANCH BLOCK 
          It is a abroad band which usually divides into two divisions namely the left 
anterior fascicle and left posterior fascicle 1, 2. These divisions showed are thought 
of as groups of interconnecting fascicles as opposed to individual, insulated, free 
running divisions. 
          The A V Node contains slow    conduction   fibers and is mainly responsible 
for the delay in the conduction of impulses from the atria to the ventricles, while 
the HIS Bundle and the trifascicular conduction systems are composed of rapidly 
conducting HIS –PURKINJE system 1,2,23,24,25. 
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          The Purkinje system consists of very large fibers, even larger then the 
normal ventricular fibers. The rapid transmission of impulse by purkinje system is 
probably caused by increased number of plexuses between the successive cardiac 
cells that make up the purkinje fibers. They have very few myofibrils and barely 
contract during the course of impulse conduction. 
             The terminal purkinje fibers penetrate about 1/3 rd of the the muscle mass 
and up to terminates the muscle fibers 23, 24, 25. 
 
BLOOD SUPPLY OF CONDUCTION SYSTEM  
S.A NODE                           ----     Right coronary artery 
A.V NODE                          ----     Right coronary artery 
A.V BUNDLE                     ----     Branch of Right coronary artery 
BUNDLE BRANCH           ----     Left coronary artery 
Posterior fascicle alone has a blood supply from both coronary arteries 1, 2,23,24,25. 
 
INNERVATION OF THE HEART 
           It is by the cardiac plexus. This is supplied with both sympathetic and 
parasympathetic fibers. It is situated at the base of the heart and is divided in to a 
superficial and deep part, which is closely connected, several small ganglia are 
found in the plexus. The largest and most constant being the cardiac ganglion 1,2,25. 
The superficial part of the cardiac plexus lies below the area of aorta, anterior to 
the right pulmonary artery. 
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                 The deep part of the cardiac plexus is situated in front of the bifurcation 
of the trachea, above the point of division of the pulmonary trunk and posterior to 
the aortic arch. The left coronary plexus gives branches to the left atrium and left 
ventricle. 
                  Sympathetic fibers are concerned with cardiac acceleration and dilation 
of coronary arteries, while the parasympathetic fibers are concerned with slowing 
of the heart, rate and constriction of coronary arteries 1, 2, 23, 24. The intrinsic cardiac 
nerve cells are limited to the atria and the interatrial septum. They are most 
numerous near the A V and S A nodes. 
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ELECTRO PHYSIOLOGY OF THE CONDUCTION 
SYSTEM 
           Along with nerve, skeletal muscle, and smooth muscle, heart muscle is one 
of the excitable tissues of the body 1,2,26. It shares the biochemical properties with 
other excitable tissues but has unique electrical features as well. The electrical 
activity of the heart is responsible for coordinating the sequence of cardiac 
activation and contraction.  Understanding the normal electrocardiogram (ECG) 
requires a substantial knowledge of normal cardiac electrophysiology. 
THE SARCOLEMMA 
           The sarcolemma of cardiac cells is comprised of phospholipids bilayer with 
its associated membrane and fluid components. So that the membrane had been 
linked to a collection of protein icebergs floating in a lipid sea. The extrinsic 
protein often are glycocylated and provide structural support to the sarcolemma. 
The intrinsic protein serves as receptors to ion channels and pumps. 
IONIC CHANNELS  
              Ionic channels are components of the membrane that permit movement of 
ions across the hydrophobic barrier of the cell membrane. These channels are 
thought to be membrane- spinning protein that contains water so that hydrated ions 
can cross the membrane. The channel selective to certain ions. Na+ channel 
preferentially conducts Na+ and is less permeable to K+ or Ca2+ ions. Also 
channels have gating mechanism i.e, they may be open or closed  depending on 
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the chemicals(agonists)in the channel or the  transmembrane voltage field, the 
degree to which the is open may vary once open. Channels have characteristic 
open times, 1ms for Na+ channels and more than 100 ms for Ca2+ channels. Each 
channels seem to operate independently i.e., the probability that a channel will be 
open or close is not influenced by the state of neighboring channels.            
                 
              Three different membrane ion channels play important roles in causing 
voltage changes of action potentials in the cardiac muscle. 
         1) Fast SODIUM channels 
         2) Slow CALCIUM-SODIUM channels 
         3) POTASSIUM channels. 
  
RESTING TRANSMEMBRANE VOLTAGE 
      Cardiac cells have a large transmembrane voltage difference during diastole, 
about -60 to -90 mv relative to the extra cellular fluid potential. This resting tran 
smembrane voltage or potential is an important factor in the electrical behavior of 
the cell.e.g, determining the action potential and also in regulating the trans 
membrane ion transport. In normal cardiac muscle the resting transmembrane 
concentration gradients for ions such as K+ and Na+ are established by active 
ionic pumping and the membrane conductance for those ions. 
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THE SODIUM PUMP 
        There is significant resting Na+ influx in cardiac cells. If Na+ ions were not 
extruded by the cell, the resting potential would decrease as Na+ ions were 
accumulated. Extrusion of Na+ from the cell requires energy because both 
electrical and chemical gradients oppose removal of Na+. The energy for Na+ 
pumping is provided by the alpha subunit of membrane associated  Na-K 
adenosine triphosphatase (ATP ase) that extrudes three Na+ and pumps in two K+ 
for each molecule of ATP that is hydrolysed . This enzyme is stimulated by 
catecholamines and inhibited by digitalis glycosides. The activity of the Na+ pump 
is electrogenic, i.e,more positive change is pumped out than pumped in (3:2 Na+-
K+ ratio)1,2. Under resting conditions the pump current makes contribution to 
resting membrane potential. Under conditions of increased Na+ entry, (e.g., 
increased heart rate), pump current will contribute more to diastolic membrane 
potential driving to more negative values. 
 
 THE CARDIAC ACTION POTENTIAL 
               Like other excitable cells cardiac cells produce an action potential when 
activated. Of all the excitable cells in cardiac cells have the longest action 
potentials their repolarization is the slowest. The cardiac Purkinje fiber action 
potentials has FIVE phases 
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PHASES: 
0- Rapid depolarization 
1-  Immediate rapid repolarization 
2- Slow repolarization or plateau 
3- Rapid repolarization 
4- Diastolic interval. 
       Other cardiac cell types have distinctive action potential contours that 
differ markedly from that of the purkinje fibers. They can be thought of as 
belonging to one of two major groups, fast or slow action potentials. 
 
FAST ACTION POTENTIALS AND FAST CONDUCTION 
               Most cardiac cells, such as ordinary or specialized atrial fibers, purkinje 
fibers, and ventricular muscle cells, have fast action potentials. These cells have 
high resting membrane potentials, and when activated, generate a fast-rising, large 
amplitude phase 0. This type of phase 0 is associated with very rapid conduction 
cells with fast action potentials tend to have completed and highly developed 
intercellular connections. The large surface area of complex cellular junctions 
provide a low resistance pathway for current most highly developed in purkinje 
fibers ,and conduction is most rapid in these fibers. 
           Fast action potential in the heart is generated by an inward rush of Na+ 
through an ionic channel that is selectively permeable to Na+ ions when the cells are 
activated. The fast channels are activated when membrene potential is rapidly 
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brought from it resting valve of -90 mv to the threshold voltage, about -75mv. The 
Na+ channel is activated quickly, inactivated quickly (time constant 0.5 to 2 ms) and 
has a very high value for maximum ionic conductance when fully activated. The 
Na+ channel is only open for 1 ms to 2 ms, but the inward Na+ current is intense 
during that moment. The main modulator of Na+ channels conductance is the value 
of resting membrane potential decreases and becomes less and less negative ,the 
Na+ channels will inactivate more and more so that the inward Na+ current during 
activation become less and less intensive .The weaker in the  Na+ current ,the 
smaller the amplitude and rate of rise of phase 0 and the slower impulse conduction 
will be at a resting membrane potential of about -60 mv ,the Na+ channels is totally 
inactivated  and no response can be elicited even with very strong stimulus. When 
the Na+ channels activates from a normal resting membrane potentials the intense 
potential to very positive valves (+30mv) ,When the channel inactivates rapidly and 
will remain inactivated and incapable of responding to stimuli until the cell 
repolarizes, the Na+ channel reactivates progressively and reaches its maximum at 
membrane potential near -90 mv 1,2 . When the cell has to polarize to -65 mv or so, it 
can be activated again, however stimulation at this low value of membrane potential 
gives rise to very low amplitude, slow-rising action potential. As repolarization 
proceeds from -65mv to -85mv, response to premature stimulation will yield action 
potentials with larger amplitude and faster depolarization rates. 
            This voltage dependent responsiveness of fast action potentials is an 
important factor in arrhythmogenesis and operates in abnormal parts of the heart, 
 14
where cells are depolarized for intense, by local hyperkalemia, by stretch injury or 
during premature activation. The Na+ channels are blocked by TTX and many anti 
arrhythmic drugs with class I action but not by Ca2+ channel blocking drugs. 
 
SLOW ACTION POTENTIALS AND SLOW CONDUCTION. 
                   The action potentials of sinus node P cells and atrioventricular (A.V) 
nodes N cells are very characteristic and quite similar. These cells have a low 
maximum diastolic value of membrane potential and a small amplitude and 
relatively slow rising upstroke ,i.e. phase 0, when they are activate potentials are 
associated with very slow conduction. 
                    So, there are anatomic reasons for the slow conduction in the sinus node 
and A V node. The cells to cell connection between sinus node P cells and A V node 
N cells and their neighbors are sparse and primitive, contributing to the slow spread 
of excitation in these structures. 
                   The ionic basis for low potentials in anionic channel that, when 
activated, is selectively permissible to calcium (Ca2+) and to a lesser extent. To 
sodium ions, the channels that carries slow inward current activates at rather 
positive valves of membrane potential such a -40 mv to -50 mv .The  slow or L type 
Ca2+ channel activates (open) slowly, inactivates slowly ( time constant 50 ms to 
100 ms ) and has a low valves for maximum ionic conductance. When fully 
activated. The conductance of the channel is regulated to some extent by resting 
membrane potential and increased substantially by catecholamine. The L type Ca2+ 
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channel can be blocked by manganese or by drugs such as verapamil, diltiazem or 
nifedipine. 
                The slow propagation in the sinus and A V node permits reentrant 
excitation to occur in very small areas despite the long refractory period found in 
cardiac muscle. 
      
SLOW ACTION POTENTIALS IN FAST FIBERS  
                      Under abnormal circumstances, fibers that normally give rise to fast 
action potentials can develop slow action potentials for  example, purkinje fibers, 
the prime example of a fast fiber type can develop slow action potentials under a 
variety of conditions, increasing the extra cellular K+ concentration to above 16 
meq/lit will reduce the resting membrane potential of a purkinje fibers, the threshold 
for the Ca2+ channels will shift in a negative direction and the maximum inward 
Ca2+ current obtained during activation will increase under these circumstances, 
electrical stimulation of the purkinje fiber will evoke a slow responses are 
unaffected by Na+ channels blocking agent such a TTX but are abolished by Ca 2+ 
channel blocking agents. Action potential of actually ischemic cells resembles the 
slow responses that occur in high K+, high catecholamine conductions. 
                    Under these conditions, the slow depolarization probably is caused by 
depressed Na+ channel action potentials. Ischemic slow action potentials are 
abolished by selective Na+ channel blockers such as TTX but not by Ca2+ channel 
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blockers. Purkinje fibers can generate slow action potentials during a variety of 
abnormal condition via a variety of ionic mechanisms. 
REPOLARIZATION OF CARDIAC ACTION POTENTIALS 
               One of the most striking attributes of the cardiac action potential is its long 
plateau, membrane potential remains more positive than -50 mv for several hundred 
milliseconds. This contrast with the brief action potentials of peripheral nerves and 
skeletal muscle fibers which typically last for less than 5ms.The long plateau 
provides adequate Ca2+ for contraction and prevents very rapid heart rates. Several 
ionic mechanisms are known to contribute to the long plateau. 
               First, K+channels in purkinje fibers show inward going rectification 
positive to -50 mv so that the outward repolarization currents carried by K+ 
decrease during the plateau of the action potential. Second, the cell tends to be held 
at plateau voltage by inward current carried by Na+ and Ca2+. The slow or 
secondary inward current normally is triggered by the depolarization caused by 
phase 0 of the action potential, during the plateau, the small inward and small 
outward currents are almost perfectly balanced so that membrane potential changes 
very little for 200 ms to 400 ms. phase 3 of the action potential is due to inactivation 
of iCa –L and activation of Ik, an outward current. As the slow channel inactivate 
the iCa-L decreases and the cell tends to repolarize. 
               The K+ accumulate in narrow extra cellular cleft may play a role in 
repolarization and certainly complicates attempts to study repolarizing K+ currents 
in multicellular preparation with voltage clammy techniques. 
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                The normal heart beat is governed by a specialized system that 
spontaneously generates and distributes each impulse though the heart in a 
coordinated way. Normally, spontaneous impulse generation is much faster in the 
sinus node (60 to 100 beats/mints) than in the sinus nodes in control of cardiac 
rhythm. 
VELOCITY OF CONDUCTION IN CARDIAC TISSUE 
                       TISSUE          CONDUCTION RATE(m/sec) 
                     S-A node                         0.05 
                Atrial pathways                            1 
                    A-V node                           0.05 
                 Bundle of HIS                             1 
               Parkinje system                             4 
              Ventricular muscles                              1 
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TIME TAKEN FOR IMPULSE TO TRAVEL 
 
    TRAVELING PATHWAY                    TIME (seconds) 
   S-A node to A-V junctonal fiber                      0.04 
    Junctional fibers to A-V bundle                       0.11 
   A-V Bundle to purkinje termination                       0.03 
     Purkinje to cardiac muscle                       0.03 
 
CONDUCTION DISTURBANCE --- BASIC PRINCIPLES 
                     Among various forms of intraventricular block, bundle branch block 
is most common and best recognized. 
                                 The various intraventricular conduction disturbances are… 
1) Right bundle branch block 
2)  Left bundle branch  block 
3) Left Anterior fascicular block 
4) Left posterior  fascicular block 
5) Bifacicular block 
6) Trifacicular block 
7) Non specific intra ventricular conduction disturbance. 
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BASIC PRINCIPLES 
                        If one of the branches of the bundle of HIS is blocked by disease, 
the impulse travels down to the other ventricle first having activated this ventricle 
the impulse spreads through the septum to the ventricle on the side of the block 
and in turn activates it. Thus the ventricles are activated one after the other instead 
of simultaneous activation. This results in prolongation of the QRS interval and S- 
T segment slopes off in the direction opposite to the main QRS deflection in cases 
of bundle branch black. 
                The incidences of RBBB and LBBB are equal in the Framingham study. 
In patients with evidence of cardio vascular disease most of the (Am. J.Card 1981; 
47,931) patients who developed LBBB had antecedent or shortly to appear 
Hypertension, cardiomyopathy or symptomatic ischemic heart disease, 40, 42, 46. 
                Bundle branch block can be produced by involvement of the fibers in the 
branch or in the HIS bundle itself by many pathological processes. Very 
commonly it is due to either ischemia or fibrosis associated with ventricular 
hypertrophy as in systemic hypertension. 
               Same conditions can also be responsible for other types of intraventricular 
conduction disturbances in the form of fascicular block. In most patients, 
unifasciculsr, bifascicular or trifascicular disease is secondary to readily apparent 
organic heart disease 46. This is associated with increased fibrosis with secondary 
involvement of the Trifascicular conduction system. 
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            Histologicaly in hypertensive and arteriosclerotic heart disease, moderate 
fibrosis, fatty infiltration and arteriosclerosis were present in the approaches to the A 
V node in some cases. 
           In other cases there were complete fibro elastic disruption of right bundle 
branch. The penetrating bundle with the seat of moderate fibrosis, while the 
branching bundle showed marked fibrosis in few cases. 
          Some intra ventricular conduction disturbances are due to a diffuse 
conduction delay during the entire ventricular depolarization rather than because of 
a localized block at one of the bundle branches. The QRS configuration in such 
cases will be an exaggeration of the underlying QRS complex. This type of defect is 
known as diffuse or non specific intraventricular conduction defect. It superficially 
resembles LBBB but lacks its characteristic features. Some times encountered in 
elderly even with out significant heart diseases. 
            Bundle branch blocks are recognized by their prolongation of the QRS 
interval 23,24,25,29. While some defects like the anterior or posterior fascicular block 
are associated with normal QRS interval. LBBB tends to produce more widening of 
QRS than RBBB. 
           Bundle branch block is commonly fixed and permanent but it may occur 
intermittently. Intermittent Bundle branch block may either depend upon heart rate 
or independent of heart rate 23, 24. 
           When the conduction defect involves both the right and left branches 
“Bilateral bundle branch block” occurs which may present as one of the many forms 
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of Bundle branch block depending up on which part of the conduction system is 
involved  23,24,25.  
          Complete AV block is produced when the block in both the bundle branches is 
complete. Bundle branch block can be encountered in normal as well as in diseased 
heart but the presences of left bundle block nearly always indicate a diseased heart. 
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DIAGNOSTIC CRITERIA OF CONDUCTION DEFECT 
DIAGNOSTIC CRITERIA OF “RIGHT BUNDLE BRANCH BLOCK” (RBBB) 
         It results from conduction delay in any portion of the right sided intraventricular 
conduction. The delay occurs in the main right bundle branch itself, in the branch of 
HIS or in the distal right ventricular conduction. 
         RBBB is also a variety of Unifascicular block. However in this Unifascicular 
block impulses are delivered by the left bundle branch and then must cross the septum 
to activate the right ventricle. This produces QRS widening. Complete RBBB is 
characterized by a wide QRS of >0.12 sec. The essential electrocardiograpic features 
of RBBB are, 
1) QRS complex 120 msec or greater 
2) Broad, notched R’ waves (rsr’, rsR’) in right precordial leads. (V1and V2) 
3) Wide and deep S wave in left precardial leads (V5 and V6). 
4) Secondary S-T and T wave changes in V1 to V3. 
CLINICAL SIGNIFICANCE 
              It is a common finding in general population and many patients with RBBB 
have no clinical evidence of structural heart disease 1, 2, 23, 24. 
               However new onset RBBB does produce a higher rate of coronary artery 
disease, congestive heart failure and cardiovascular mortality. 
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                  Brugada syndrome has been described in which a RBBB like pattern with 
persistent S-T segment elevation in right precordial leadsand its is associated with 
susceptibility to ventricular tachyarrhythmia and sudden cardiac death.   
                The diagnosis of RVH is more difficult when it is assocoated with RBBB 
because of the accentuated positive potential in lead V1, RVH is suggested 1, 23,24,25,26.  
  
   LEFT BUNDLE BRANCH BLOCK 
             In this condition the left ventricle is activated after the right ventricle and 
initial septal action begin from right to left instead of the normal left to right. 
            It is due to conduction delay or block in any of several sites in the 
intraventricular conduction system, including the main left bundle branch ,in each of 
the two fascicles or less commonly  within the fibers of the bundle of HIS that 
become the main left bundle branch block. 
 DIAGNOSTIC CRITERIA. 
1) QRS duration 120 msec or greater 
2) Broad, notched R waves in lateral precordial leads (V5 and V6) and 
usually Lead I and   aVL. 
3) Small or absent initial ‘r’ waves in right precordial leads (V1 and V2) 
followed by deep S waves. 
4) Absent septal  q waves in Left sided leads. 
5) Prolonged intrinsicoid deflection (> 60 msec in V5and V6). 
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CLINICAL SIGNIFICANCE 
              The presence of LBBB almost always indicates a disease of heart 1, 2, 24, 25, 
particularly coronary and hypertensive heart disease, less commonly it may be 
encountered in cardiomyopathy, myocarditis, and congenital heart disease. 
             LBBB in an apparently healthy heart is extremely unusual. It is more common 
than RBBB in elderly individuals with diseased heart. It is associated with reduced 
long term survival and with 10 yrs survival rates as low as 50%. It reflects the severity 
of the underlying cardiac disease.                                                                                             
             The duration of the QRS complex in LBBB correlate inversly with left 
ventricular ejection fraction 1,23,23,24.                                                                               
FASCICULAR BLOCKS 
                Under normal conditions activation of left ventricle begins simultaneously 
at the insertion sites of the fascicles. It results in activation of these sites sequently 
rather than simultaneously. 
  LEFT ANTERIOR FASCICULAR BLOCK 
                 Since the impulse conducted via the posterior division is directed 
superiorly and to the left, a marked left axis deviation is observed in LAFB. 
DIAGNOSTIC CRITERIA 
1) A narrow QRS complex    --- Less then or equal to 120 msec 
2) Left axis deviation             --- mean QRS axis -45 to -90. 
3) rS pattern in the leads II ,III and aVF.  
4) qR pattern in lead aVL 
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CLINICAL SIGNIFICANCE. 
                 LAFB is common in person with  overt cardiac disease.  It has minimal 
or no independent prognostic significance. It is associated with cardiac and systemic 
condition like MI, especially occlusion of the left anterior descending coronary 
artery, LVH, hyper tropic and dilated cardiomyopathy and degenerative disease 1, 
2,23,24,25. 
                The development of LAFB with rS complexes in II, III and aVF can mask 
the Q wave of a prior inferior myocardial infarction. 
LEFT POSTERIOR FASICULAR BLOCK 
                   Conversely in LPFP, left ventricle is activated via intact anterior 
division. Since the impulse conducted through the anterior division is directed 
inferiorly and to the right, right axis deviation is produced. 
 DIAGNOSTIC CRITERIA 
1) Frontal plane mean QRS axis less than 120 degrees 
2) RS pattern in leads I and aVL with qR patterns in inferior 
leads. 
3) QRS duration of less than 120 msec  
 CLINICAL SIGNIFICANCE. 
                     This is rare to occurring in a healthy individual. The incidence of left 
posterior hemi block is much lower than LAFB 1, 2, 23, 25. The possible explanation 
being the posterior division is shorter and thicker than and less influenced by the 
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stresses of out flow pressure, because of its inflow tract structure It also have a 
double  blood supply compared to the anterior fascicle. 
BIFASCICULAR BLOCK 
                It refers to the block of two fascicles of the trifascicuiar conduction 
system. The combination producing bifacicular blocks are, 
             1) Pre divisional block of LBBB 
              2) RBBB with LAFB  
              3) RBBB with LPFB 
                RBBB with LAFB is diagnosed when V1demonstrate RBBB and frontal 
plane leads demonstrate Left axis deviation. 
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SYSTEMIC HYPERTENSION 
DEFINITION 
           It is a disorder of circulatory regulation and continuous variable and 
whatever number is used to define Hypertension will be Arbitary. The lower limit 
for the definition of hypertension has changed from 160/95 to 140/90 mm hg. 
          It is another way to expressed by lateral force exerted by the blood column 
per unit area of the vascular wall that is expressed in mm Hg.  
     
JNC-7 CLASSIFICATION FOR HYPERTENTION 
BP Category BP Range(sys,dias 
in mm hg) 
Lifestyle 
modification 
Drugs 
Normal <120 and <80 Encouraged Not indicated 
prehypertension 120-139 or 80-89 Recommended Not indicated 
Stage-I 140-159 or90-99 Recommended Single drug 
Stage-II >160 or>100 Recommended Double drugs 
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Threshold Values for NORMAL versus ABNORMAL Blood Pressure 
(mm Hg) 
Source Office readings Home Readings Ambulatory BP 
Jnc-7 140/90   
Tsuji et al. 140/90 137/84  
De Guademaris et 
al. 
140/90 127/83  
Pickering 140/90 135/85 135/85 
Staessen et al. 140/90  133/82 
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HISTORY OF HYPERTENSION 
YEAR 
 
EVENTS 
1773 Stephen Hales measured BP for the first time in HORSES by 
measuring height of a column of blood in a vertical tube 
inserted in to CRURAL artery.      
1895         Riva Rocci invented sphygmomanometer 
1896 Sir, Clifford Albert- made distinction between Hypertension 
due to Renal disease and Hypertension in which no renal 
pathology can be found. 
 
1898 Tigersteds and Bergman isolated rennin from renal cortex 
1904 Amleard and Beayard studied Hypertension patients and 
observed a positive chloride balance associated with arise in 
Blood pressure. 
 
1915 M.C Korokoff, Russian surgeon introduced Auscultatory 
method of recording Blood pressure. 
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CAUSE OF HYPERTENTION 
         I .SYSTOLIC and DIASTOLIC  
               A) PRIMARY/ESSENTIAL or IDIOPATHIC 
                             It is idiopathic but it believed that arises as a result of 
multilateral condition, factors that produce hypertension.   
GENETIC FACTORS 
       MONOGENIC FORMS 
a) Glucocorticoid – remediable aldosteronism 
b) Liddle’s Syndrome. 
        POLYGENIC FORMS 
a) Angiotensinogen gene 
b) Na+-Li + Counter transport 
c) Epithelial amiloride – sensitive sodium channel 
d) Nitric oxide generation 
e) Alpha- adducin defect 
f) G beta 3 subunit  
g) Insertion /deletion of ACE gene 
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B) SECONDARY  
       1) RENAL CAUSE 
                     
                      A) RENAL PARENCHYMAL DISEASE 
                              1) Acute glomerulonephritis 
                              2) Chronic Nephritis 
                              3) Polycystic disease 
                              4) Diabetic Nephropathy 
                              5) Hydronephrosis 
                       B) RENOVASCULAR CAUSE 
                               1) Renal artery stenosis 
                               2) Intrarenal vasculitis 
                        C) RENIN PRODUCING TUMOURS 
                        D) PRIMARY SODIAM RETENTION 
                                       Liddle’s and Gordon’s syndrome 
     2) ENDOCRE 
                                 a)Acromegaly                                                            
 b) Hypothyroidisum 
                                 c) Hyperthyroidism 
                                 d) Hypercalcemia 
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                            e) Adrenal  
                                              1) Cortical 
                                                     i) cushing’s syndrome 
                                                      ii) Primary aldronism 
                                                      iii) Congenital adrenal hyperplasi 
                                                      iv) Apparent mineralocorticoid excess (licorice) 
                                             2) Medulary cause -- pheochromocytoma 
                             f) External chromatin producing tumours 
                             g) Carcinoid 
                              h) Exogenous hormones 
                                                 1) Estrogen 
                                                 2) Glucocorticoids 
                                                 3) Mineralocorticoids 
                                                 4) Sympathomimetics  
                                                 5) Tyramine containing foods and  
                                                 6)   Monoamine oxide inhibitors 
   3) COARCTATION OF AORTA 
  4) PREGNANCY INDUCED HYPERTENTION 
  5) SLEEP APNEA 
   6) NEUROLOGICAL DISORDER 
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             a).Increased intracranial pressure 
1) Brain tumor 
2) Encephalitis 
3) Respiratory acidosis 
4) Quadriplegia 
5) Acute porphyria 
6) Familial dysautonomia 
7) Lead poisoning 
8) Guillain – barre  syndrome 
             b)ACUTE STRESS ( INCLDING SURGERY) 
1) Psychogenic hyperventilation 
2) Hypoglycemia 
3) Burns 
4) Pancreatitis 
5) Alcohol withdrawal 
6) Sickle cell crisis 
7) Post resuscitation 
8) Post operative 
9) Increased intravascular volume 
10) Alcohol and drug use 
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II) SYSTOLIC HYPERTENSION 
A) INCREASED CARDIAC OUTPUT 
1) Aortic valvular regurgitation 
2) Aortoventricular fistula , patent ductus arteriosus 
3) Thyrotoxicosis 
4) Paget ‘s disease of bone 
5) Beriberi 
6) Hyperkinetic circulation 
B) RIGIDITY OF AORTA 
III) IATROGENIC HYPERTENSION 
A) DRUGS 
7) Non steroidal  anti –inflammatory drugs 
8) Sympathomimetic amines 
9) Estrogen and estrogen analogs 
10) Corticosteroids 
11) Methylxanhtines 
12) Cyclosporine’s 
13) Erythropoietin 
14) Cocaine 
15) Nicotine 
16) Phencyclidine 
17) Herbal ecstasy 
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18) With drawal from certain Drugs 
a) Beta blocker 
b) Alpha agonist 
c) Opioids 
d) Ethanol 
e) Calcium antagonist 
 
PREVALENCE OF HYPERTENSION 
      AGE ( IN YEARES)       HYPERTENSIVES % 
               18-29                        4 
               30-39                        11 
               40-49                         21 
               50-59                        44 
               60-69                        54 
               70-79                        64 
                >80                        65 
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FACTORS AFFECTING HYPERTENSION 
1) VASCULAR RESISTANCE 
2) ENDOTHELIAL CELL FUNCTION 
Affected by; a) blood viscosity 
b) Vascular wall stem condition 
c) Blood flow velocity  
d) Arterial wall thickness 
 
 
EARLY HYPERTENSION 
                         It is mainly due to increased Cardiac output with out change of 
peripheral resistance. 
FACTOR MEDIATED ARE: 
1) Increased tissue demand or hypervolemia 
2) Cardiac stimulation as by adrenergic hyperactivity 
3) Slight hypokalemia with hypercalcaemia  
4) Na+-Ca2+ exchange mechanism. 
CHRONIC ESTABLISHED HYPERTENSION 
          Here the Cardiac output was normal or reduced variable mechanism 
1) increased vascular resistance 
2) decreased diameter of arteriolar lumen  
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3) Increase vasoactive factors enhance reactivity of smooth muscle cells 
or structural change in vessel wall. 
 
THEORIES TO EXPLAIN THE CHANGES 
1) THEORY OF AUTO REGULATION 
                Initial high Cardiac output cause over perfusion of tissues and 
secondary rise in systemic vascular resistance to counter balance the increase in 
flow, this restore the cardiac output to normal valve. 
   (Guyton et al, Leeding ham, Pelling) 
2) PRIMARY PATHOLOGICAL CHANGE IN PERIPHERAL     
VASCULATURE OR VASCULAR REMODELLING 
THEORY 
a) Hypertrophy of smooth muscles of resistance vessels in which 
vascular endothelium play an important role by its release of 
growth factors and biochemical mediators, 
b) These changes causes increased vascular resistance. 
3) GENETIC THEORY 
a) Primary hypertension is a polygenic trait, sharing strong 
dependence on multiple environmental factor as well as 
heterogeneity of genes. 
b) ACE gene, Angiotensinogen, AT receptor gene is also responsible. 
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c) Salt sensitivity and volume factors may play an important role in 
pathogenesis. 
 
 
ISOLATED SYSTOLIC HYPERTENSION 
              In this entity the systolic blood pressure then 140 mm hg with diastolic 
blood pressure of less than 90 mm hg 1, 2, 40, 42. 
CAUSES ARE: 
        a) Remediable functional causes like  
             -- Increased stroke volume and increased adrenergic activity. 
        b) Non- remediable structural cause 
              -- Athererosclerotic changes of vascular wall 
       During therapy improvement of large arterial compliance should be a goal 
because systolic blood pressure is an important determinant of myocardial wall 
stress. 
                                                                                                                                                                                     
HYPERTENSIVE HEART DISEASE 
                     Heart is one of the organs most affected as a consequence of direct 
and indirect effects of hypertension. Direct effects account for the presence of Left 
ventricular hypertrophy and the resultant hypertensive disease 33, 34,40,41,42. It is an 
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adaptive mechanism of the heart of the systolic overload of the left ventricle due to 
increased peripheral vascular resistance. 
                       Left ventricular hypertrophy is defined as an increase in the muscle 
mass of left ventricle. The increases in muscle mass lower the coronary reserve 
and enhance the cardiac oxygen requirement. LVH is an independent risk factor 
for sudden death for myocardial death, congestive heart failure and other 
cardiovascular morbidity. The Framingham heart study has documented that the 
risk of these complications increases six to eight fold with the occurrence of Left 
ventricular hypertrophy. 
 
MORPHOLOGICAL PATTERNS OF LVH 
                        The classic form of CONCENTRIC HYPERTROPHY is defined 
as a thickening of the septum and posterior wall of the left ventricular at the 
expense of the chamber volume.  
                        ECCENTRIC HYPERTROPHY is the thickening of the chamber 
wall with concomitant chamber dilatation. It occurs in the late phase of 
hypertensive heart disease a precursor of congestive heart failure. 
                        Pathological cardiac hypertrophy may be associated with adverse 
effects on cardiac muscle including.. 
1) Altered diastolic tension 
2) Increased college content 
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3) Alterations in Myocardial perfusion 
4) Abnormal electrophysiological properties 
5) Decrease contractility 
RENIN-ANGIOTENSIN SYSTEM –IT’S ROLE IN LVH 
              It is suggested that chronic activation of Renin-angiotensin system and, 
ventricular loading is associated with the development of myocardial fibrosis in 
the Right and Left ventricle there appears irrespective of myocyte hypertrophy or 
necrosis. 
            In this regard the role of Renin-angiotensin, bradykinin, prosotaglandin 
system in regulation of myocardial collagen metabolism is well documented 
34,44,45,46. 
MYOCARDIAL COLAGEN MATRIX 
              The major structural proteins of the myocardial collagen matrix are the 
fibrillar collagen type I and type II. The concentration of type I determine stiffness 
of the myocardium. Myocardial fibroblasts contain the mRNA for type I and III 
collagens. An increased level of mRNA and collagen synthesis occurs in the 
myocardium in response to the Angiotensin II stimulation of fibroblast. While 
prostaglandin E2 inhibit the collagen synthesis in the fibroblast, collagen 
degradation is mainly effected through the enzyme MMP-1(matrix metallo 
protein), a key enzyme in collagen degradation. 
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ANGIOTENSIN II 
              It appears to be responsible for the disproportionate and diffuse 
accumulation of fibrillar collagen within the cardiac interstitium in hypertensive 
heart disease. while PG E2 counteracts the adverse tropic effects of Angiotensin II 
on myocardial collagen matrix. 
 
ANGIOTENSIN  RECEPTORS 
        The direct effect of Angiotensin II on cardiac fibroblasts require the presence 
of specific receptors on these cells .The presence of such Angiotensin II receptors 
type I and type II on cardiac fibroblasts and human myocardium has been shown. 
         AT-1 receptors is predominantly involved in the mediation of collagen 
synthesis whereas MMP-I inhibition by Angiotensin II may be mediated through 
AT-2 receptor. Other factors that may be involved in the myocardial remodeling in 
hypertensive heart disease could be the Insulin like growth factor I, receptors to 
catecholamine which may decrease the fibroblast mediated collagen synthesis. 
          These findings suggest that a direct interaction between Angiotensin –II and 
PGE 2 and cardiac fibroblast could be of major importance in requiring 
myocardial fibrosis. Chronic inhibition of cardiac angiotensin converting enzyme 
would induce both inhibition of myocardial angiotensin II generation and 
elevation of myocardial PGE2 levels. 
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                  This may explain why the ACE inhibitors Lisinopril has been shown to 
be a powerful agent in regressing myocardial fibrosis in hypertensive heart 
disease. 
INVOLVEMENT OF CORONARY CIRCULATION 
                    Patient with hypertrophied ventricles often exhibit signs and 
symptoms of myocardial ischemia in the absence of coronary artery obstructive 
disease. This has been proved by many angiographic studies in hypertensive 
patients who complain of anginal pain. These patients often demonstrate abnormal 
finding in exercise electrocardiography and myocardial Thallium 201 scan and 
abnormal lactate metabolism during pacing, suggestive of myocardial ischemia. 
                     Studies in animals and men indicate that the major conduit epicardial 
coronary vessels are enlarged in hypertrophied ventricles. This is however less 
compared to the amount of increase in ventricular mass. This may result in a 
minor increase in total coronary resistance. 
                The effect of hypertrophy on smaller coronary arterial vessels remains 
controversial.Although some qualitative studies have suggested various 
abnormalities, an extensive quantitative studies have suggested various 
abnormalities an extensive quantitative study on dogs by Tomanek et al .has not 
demonstrated any consistent adverse alteration in resistant vessels. No significant 
alterations in wall to lumen ratios, were observed in coronary arterial vessels over 
a large range of sizes even though physiological measurements reveled significant 
increase in minimal coronary vascular resistance. 
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CAPILLARY DENSITY  
                Many studies have demonstrated a decrease in capillary density in the 
subendocardial layers of hypertrophied ventricles secondary to pressure overload 
33,35,36,40
. This may result in  increased diffusion distance, the significance of this to 
be defined by further study. 
                 The physiological function of coronary collateral circulation is not 
enhanced by the pressure induced cardiac hypertrophy. 
EFFECT OF LVH ON CORONARY RESERVE 
               Both volume and pressure induced hypertrophy in patients of all ages are 
associated with moderately decreased coronary reserve 33, 35,40,41,42. This has been 
readily demonstrated in various studies. 
              The impairment of coronary reserve in arterial hypertension is mainly 
based on structural and functional alteration in the coronary resistance vessels 41, 
42
. Myocardial hypertrophy also increases the extravascular compressive forces 
that elevate the extra vascular component of coronary resistance due to myocyte 
hypertrophy and interstitial and perivascular fibrosis. 
               Coronary reserve may also be impaired due to increased metabolic 
demands under baseline conditions. These changes result in an abnormal perfusion 
of the hypertrophied ventricles and it severe enough may lead to intermittent 
episode of severe subendocardial ischemia and eventually to diffuse sub 
endocardial fibrosis. 
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           Recent electrophysiological studies by Martins et al have demonstrated that 
in the presence of myocardial ischemia conduction abnormalities and rapid 
ventricular tachycardia develop in hypertrophied ventricles. 
          This view is supported by the findings of a recent study of electrophysiology 
in hypertensives which has suggested that the increased electrophysiological 
disturbances may be related to an increased amount of fibrous tissue or altered 
collagen content. 
 
PREVALANCE OF LVH 
         Data from Framingham cohort has demonstrated a prevalence of LVH of 
16% for men and 19% for women.  After the age of 70 yrs it is 30% for men and 
49% for women 43. 
         Echocardiographic data from Hammond et al have shown an overall LVH 
prevalence of 20% for patients with mild hypertension, with more severe 
hypertension,the prevalence may reach 50%.. 
DETERMINENT OF LVH  
AGE: A recent multi centre trial confirmed that there was no association of age 
with wall thickness or left ventricular mass after adjustment for BP and body mass 
index. 
SEX: Women have smaller LV mass than men for any given level of arterial 
pressure. 
 45
RACE: Black race is more prone for hypertensive complication than white race. 
OBESITY: Framingham heart study has demonstrated a NINE to TEN fold 
increase in prevalence of LVH depending on the grade of obesity. 
SALT INTAKE: Number of studies has shown that salt intake is a strong 
determinant of LVH independent of blood pressure. 
ALCOHOL INTAKE: Relationship of alcohol intake and hypertension is 
significant as indicated by the intersalt study, but the association of alcohol with 
less clear. 
        LVH has been indicated as a significant and most powerful risk factor for 
future cardiovascular events causing morbidity and mortality. LVH and its 
sequence can be reduced by specific antihypertensive therapy, Future 
epidemiological studies are necessary to document the clinical benefit of a 
reduction in LVH.   
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ECG CRITERIA TO DIAGNOSE LEFT VENTRICULAR 
HYPERTROPHY 
Sokolow-lyon index                                ---      Sv1+( Rv5orv6) > 3.5 mv 
                                                                            R aVL>1.1mv 
 
ROMHILT-ESTES POINT SCORE SYSTEM. 
1. Any limb lead R wave or S wave > 2mv                      ----          3 Points 
     Sv1or Sv2   >3mv (30 mm)                                          
     Rv5 or Rv6 > 3mv (30 mm)                                         
2.  ST-T Wave abnormality (no digitalis)                          ----          3Points 
      ST-T Wave Change with digitalis treatment               ----          1 Point 
3.  Left atrial abnormality                                                  ----          3 Points 
4. Left axis deviation > -30 degrees                                  ----          2 Points 
5. QRS    Duration > 90 Msec                                           ----          1 Point 
6. Interensicoid   deflexon   V5 or V6 > 50 Msec             ----          1 Point 
CORNAL Voltage Criteria                       ------   Sv3 + RaVL >2.8 mv(men) 
                                                                                Sv3 + RaVL > 2.0 mv(women) 
 
CORNAL Voltage equation                    ------    Risk of LVH = 1/ (1+ e –exp) 
Exp = 4.458 – 0.092 ( RaVL + SV3) – 0.306 TV1 -0.212 QRS-278 PTF V1 -0.859 
(sex) 
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NOVACODE Criterion (men) 
LVMI9gem/m2= -36.4 +0.01 RV5 + 0.2 SV1 + 0.28 SIII +0.12 TV6-0.148 
DIAGNOSTIC ACCURACY, 
Sokolow-Lyon and Romhilt- Estes Criteria    ----    Sensitivity- 10 to 30% 
                                                                                       Specificity-85 to 95% 
 
Cornal and Noncode regression method        ----    Sensitivity- 35to50% 
                                                                                                                                   Specificity- 85to95%                                                     
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MATERIALS AND METHODS 
      
  STUDY PLACE: 
              This study was conducted at HYPERTENSION CLINIC of MEDICINE 
DEPARTMENT in every Monday and Saturday in Government Stanley hospital 
during August 2004 to April 2005. 
 
STUDY POPULATION: 
               This study is based on the analysis of the ECG of 800 patients who 
attended the hypertension clinic. It included 545 male patients and 255 female 
patients. 
 
INCLUTION CRITERIA: 
1) Patient who had established hypertension and who were in regular 
antihypertensive medication. 
2) Only those patients with proved Primary hypertension were 
included in this study. 
3) Of these, patients with consistent elevation of blood pressure over a 
period of three weeks only were taken up for ECG analysis. 
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EXCLUTION CRITERIA: 
1. The patients with secondary hypertension and diabetes mellitus are 
excluded. 
2. The patients with ISOLATED SYSTOLIC HYPERTENSION are 
excluded. 
3. The patients with NON SUSTAINED hypertension are excluded. 
 
METHOD: 
              -- Blood pressure was measured in all the four limbs, recumbent, sitting 
and standing postures were used.    
              --Routine urine analysis and blood for Urea, chlostereral, Electrolyte and 
Creatinine were done. 
             -- Complete clinical examination was done to exclude the possibility of 
secondary hypertension. 
             --  Standered 12 leads ECG was taken and the patient who were having 
ECG abnormality were followed up a week later with another ECG and only 
patients with persistent abnormality were taken for analysis. 
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THE RESULT, OBERVATION AND DISCUSSION 
     
ECG CHANGE NUMBER PERCENTAGE 
Normal  ECG 498 62.25 
Myocardial ischemia 76 9.5 
Old myocardial infarction 24 3 
Left ventricular hypertrophy 
Without Strain 
With Strain 
 
64 
30 
 
8 
3.75 
Ventricular premature contraction 8 1 
Left axis deviation 20 2.5 
Conduction defect 80 10 
RBBB 14 1.75 
LBBB 8 1 
LAFB 58 7.25 
TOTAL 800 100 
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OBSERVATION 
         The ECG of 800 consecutive patients with persistent hypertension was 
analyzed for Conduction defect as described above. 
         94 cases have abnormal ECG’s of which Left ventricular hypertrophy with 
and without strain formed the main abnormality in this study. Conduction 
disturbance in the form of RBBB, LBBB, LAFB were present in 10% of cases. 
Among which LAFB was the most common type of Conduction disturbance and it 
constitute7.25%. 
         Thirteen ECG’s with LAFB also showed features of LVH with strain. Ten 
ECG’S showed LAFB had feature of Anterolateral myocardial Ischemia as well as 
one ECG with LAFB had LVH without strain. 
         Two EEG with LAFB showed evidence of old ASMI. Two ECG with LAFB 
showed LVH with evidence of diastolic overload, Eight ECG showed Ventricular 
premature Contracture. 
        Among the EEG with evidence of RBBB, six of them had Ventricular 
hypertrophy.                     
Ten ECG showing LBBB was not associated with any evidence of 
ischemia, Ventricular hypertrophy. NO case with LPFB was observed among the  
abnormal electrocardiogram. 
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INCIDENCE OF CONDUCTION DEFECTS IN MALES and 
FEMALES 
         
TYPE MALE FEMALE 
LAFB 40 18 
LBBB 5 3 
RBBB 9 5 
TOTAL 54 26 
 
 
  
INCIDENCE OF CONDUCTION DEFECT WITH INCREASING 
DIASTOILC BLOOD PRESSURE 
TYPE DBP< 140mmhg DBP > 140mmhg 
LAFB 9 35 
RBBB 4 6 
LBBB 2 3 
TOTAL 15 44 
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DISCUSSION 
From the results it is evident that conduction defects form one of the main 
ECG change in Essential Hypertension. Closely following are the incidence of 
Left ventricular Hypertrophy and Myocardial ischemia.      
     Eighteen out of eighty patients with conduction defect also showed 
evidence of Myocardial Ischemia. While fourteen out of Eighty patients with 
conduction defect showed evidence of Left ventricular hypertrophy. Nearly 50% 
of patients with conduction defect had other evidence of Hypertensive heart 
disease, which might have predisposed to the development of Inter ventricular 
conduction disturbance. 
              The sub endocardial fibrosis may be the reason for the involvement of 
conduction pathway in the thirty cases which showed no evidence of ventricular 
Hypertrophy or Ischemia. 
               When considering the relative incidence of various conduction defects in 
Male hypertensives and Female hypertensives, it is nearly 2:1 respectively for 
LAFB and LBBB. Where at it is 3:4 as RBBB was concerned. These facts indicate 
that male patients are more prone to develop cardiac complication of 
Hypertension, such as conduction disturbance. 
                When patients were arbitrarily divided into two groups depending on 
their diastolic blood pressure below or above 140 mm hg to find out if there is any 
relation of complications like conduction defects with reference to the weight of 
Diastolic blood pressure, it was found that patients showing LAFB, 35 were 
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having a BP more than 140mmhg while only 9 were having a BP of less than 
140mmhg with a ratio of 4:1. Similarly the incidence of RBBB and LBBB were 
greater with patients having a DBP of more than 140 mm hg with a ratio of 4:3 
and 2:1 respectively, suggesting that a high DBP over prolonged periods certainly 
leads to  many cardiac complication ( Myocardial ischemia secondary to LVH are 
also common with High blood pressure) 
                Though an objective study was made regarding the number of years of 
hypertension and the occurrence of conductive disturbances, no decisive inference 
could be taken, because many patients were aware of having hypertension only 
from the day they visited a doctor for some other complaint (hypertension was 
accidentally detected by them). While some patients even though , they had a few 
symptoms like headache and giddiness referable to hypertension, were having 
indigenous treatment or delayed consultation with a physician for an indefinite 
period. So the exact duration of hypertension in them could not be gauged. 
              Conduction disturbances as a part of cardiovascular complication of 
hypertension is proved once again in this study. Other studies like 
FRAMINGHAM study has shown that the incidence of Arrhythmias, Conduction 
defect and sudden death is considerably higher among hypertensives 40,42,43. 
                CHUNG in his text book on ECG states that hypertension is one of the 
commonest causes of conduction disturbances in the heart. 
               A review of Hypertension and LVH by FRANZ H. MASSERLF et al. In 
the cardiology clinics (NOV-1995) states that the increased incidence of 
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conduction disturbances in hypertensive is probably due to the increased fibrous 
tissue or altered collagen content. 
              MARTIN et al in their recent electrophysiological studies have 
demonstrated that conduction disturbances develop in hypertrophied ventricles in 
the presence of myocardial ischemia. Lot of studies has proved that presence of 
coronary ischemia with normal coronary arteries in hypertension. (CICULATION 
1-18, 1998) 
               While describing about left ventricular hypertrophy as one of the 
causes of LAFB, GOLDMAN suggests, abnormal degree of left axis deviation is 
probably not due to the hypertrophied mass as such, but to associated sub 
endocardial    fibrosis involving the LAFB. 
                      GOPINATH et al in 1994 , during their 3 years follow up study of 
hypertension in Delhi recorded ECG of 871 patients have had abnormal ECG’S 
were exhibited by 307 patients (35.2%) of which 24 patients had Myocardial 
infarct,133(15.3%) patients were had ischemic ST-T changes , 54 patients (6.2%) 
had LVH and 96 (11%) had conduction disturbances and arrhythmias. 
In our study the number of patients showing abnormal ECGs with old 
infarction, correlate very well with the above studies, while the incidences of 
conduction disturbance and arrhythmia were slightly lower—as opposed to 11%, 
the incidence of LVH was higher in our study group (11.75%)compared to WHO 
bulletin 1994:725 (6.2%).         
                                   
 56
SUMMARY 
This study was conducted among 800 patients with hypertension attending 
Hypertension clinic at GOVERNMENT STANLEY HOSPITAL – CHENNAI 
from   August 2004 to April 2005. 
 Standard 12 leads ECG was recorded in all patients and analyzed for the 
presence of intraventricular conduction defect like RBBB, LBBB, LAFB and 
LPFB ect. using the standard electrocardiographic criteria for such defects. 
Our analysis of the ECGs showed the presence of abnormal ECGs in 
37.75% of patients. Commonest abnormality is LVH (11.75%) followed by 
Conduction disturbance (10%), myocardial ischemia (9.5%), old Myocardial 
infarct (3%), Left axis deviation (2.5%), Ventricular premature contraction (1%). 
while 62.25% of patients had a normal ECG. 
The result of our studies proves that hypertension is frequently associated 
with the development of conduction disturbances and increased severity of 
hypertension may be related to increased incidence of such defect. The 
identification of which may be helpful in defining high risk groups and start 
appropriate therapy to prevent complications and to reduce the morbidity and 
mortality.           
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CONCLUSION 
1. This study proves that intraventricular conduction disturbance is one of the 
commonest electrocardiographic manifestations in Primary hypertention. 
2.  Left anterior fascicular block (7.25%) is the commonest one followed by 
Right (1.75%) and Left bundle branch block (1%). 
3. With increasing diastolic BP conduction disturbances become more 
common.          
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PROFORMA 
Name  :                                                                           Religion                   
Age      :                                                                        
Sex       :                                                                          Address                   :   
Occupation    : 
Income           : 
 
Age of onset of HT   : 
Duration of HT        : 
Treatment  History  :    Diet/Oral drugs 
Dietary Habits          :   Veg /Non-Veg/ Mixed 
Smoker                      :   Yes/No                                            Duration: 
Alcoholic                   :   Yes/No                                            Duration:  
              Amount: 
Family History          :   Hypertension                                  Yes/No 
                                          Diabetes                                         Yes/No 
                                           CAD                                              Yes/No 
                                         Hyperlipidemia                              Yes/No 
H/O Diabetes   Yes/No                      Duration      :                         Drugs; 
IHD            Angina/Infarction                                  Yes/No 
 70
Hyperlipidemia                                                            Yes/No 
CLINICAL EXAMINATION 
Hight:                                                                            BMI: 
Weight:                                                                         Sarface area: 
Pulse:                                                                            Peripheral arteries: 
BP:             Supine:                           Right UL:               Left UL: 
                 Standing:                          Right LL:               Left   LL: 
 
CVS:                              S1 S2                                                    Murmur 
RS   : 
ABDOMEN:                    Mass                    Liver                       Spleen ECG:                                                                
Rate: 
Rhythm: 
Axis: 
P wave: 
PR interval: 
QRS duration: 
QRS morphology: 
LVH by  ROMHILT-ESTES POINT SCORE SYSTEM                  
S.NO AGE SEX B.P No of years of 
Hypertension 
RHYTHM RATE QRS VAT QRS 
Axis 
QRS Configuration 
1 60 M 190/120 7 NSR 86 0.08 0.03 +30 qR in I, aVL, rS in II, III, aVF 
2 70 M 166/120 12 NSR 94 0.07 0.04 +40 qR in I, aVL, rS in II, III, aVF 
3 56 M 180/148 6 NSR 78 0.08 0.03 +15 qR in I, aVL, rS in II, III, aVF 
4 67 F 200/150 15 NSR 88 0.08 0.04 +60 qR in I, aVL, rS in II, III, aVF 
5 66 M 180/140 8 NSR 84 0.08 0.04 -15 qR in I, aVL, rS in II, III, aVF 
6 58 M 160/110 11 NSR 86 0.08 0.04 +60 qR in I, aVL, rS in II, III, aVF 
7 49 M 194/134 3 NSR 98 0.08 0.04 0 qR in I, aVL, rS in II, III, aVF 
8 62 M 200/140 4 NSR 86 0.08 0.04 -35 qR in I, aVL, rS in II, III, aVF 
9 68 M 184/124 10 NSR 102 0.08 0.04 +30 qR in I, aVL, rS in II, III, aVF 
10 58 M 168/144 5 NSR 84 0.08 0.04 +5 qR in I, aVL, rS in II, III, aVF 
11 65 F 174/122 3 NSR 82 0.07 0.03 +30 qR in I, aVL, rS in II, III, aVF 
12 61 M 158/110 6 NSR 80 0.08 0.04 -45 qR in I, aVL, rS in II, III, aVF 
13 60 M 160/132 12 NSR 78 0.08 0.04 -30 qR in I, aVL, rS in II, III, aVF 
14 55 M 168/112 6 NSR 82 0.08 0.04 +30 qR in I, aVL, rS in II, III, aVF 
15 48 M 200/164 8 NSR 84 0.07 0.03 +20 qR in I, aVL, rS in II, III, aVF 
16 70 M 180/136 4 NSR 92 0.08 0.04 +15 qR in I, aVL, rS in II, III, aVF 
17 56 F 174/142 11 NSR 74 0.08 0.04 -45 qR in I, aVL, rS in II, III, aVF 
18 58 M 180/144 5 NSR 82 0.08 0.04 +15 qR in I, aVL, rS in II, III, aVF 
19 63 F 176/120 9 NSR 80 0.08 0.03 -30 qR in I, aVL, rS in II, III, aVF 
20 69 F 184/134 13 NSR 76 0.07 0.04 -45 qR in I, aVL, rS in II, III, aVF 
21 59 M 200/146 11 NSR 70 0.08 0.04 -35 qR in I, aVL, rS in II, III, aVF 
22 62 M 178/134 7 NSR 78 0.08 0.04 -30 qR in I, aVL, rS in II, III, aVF 
23 66 M 180/154 9 NSR 92 0.08 0.03 - 45 qR in I, aVL, rS in II, III, aVF 
24 64 M 196/128 15 NSR 102 0.08 0.04 -5 qR in I, aVL, rS in II, III, aVF 
25 60 M 182/136 20 NSR 88 0.07 0.04 0 qR in I, aVL, rS in II, III, aVF 
26 50 M 176/122 9 NSR 80 0.08 0.03 +60 qR in I, aVL, rS in II, III, aVF 
27 58 M 168/134 11 NSR 108 0.08 0.04 +30 qR in I, aVL, rS in II, III, aVF 
28 65 M 156/112 12 NSR 78 0.08 0.04 +65 qR in I, aVL, rS in II, III, aVF 
C.NO AGE SEX B.P No of years of 
Hypertension 
RHYTHM RATE QRS VAT QRS 
Axis 
QRS   Configuration 
29 57 F 180/140 7 NSR 86 0.07 0.04 +30 qR in I, aVL, rS in II, III, aVF 
30 63 M 192/154 4 NSR 112 0.08 0.04 -45 qR in I, aVL, rS in II, III, aVF 
31 61 M 176/144 11 NSR 78 0.06 0.02 -30 qR in I, aVL, rS in II, III, aVF 
32 67 F 200/134 8 NSR 88 0.08 0.04 -55 qR in I, aVL, rS in II, III, aVF 
33 59 M 166/140 5 NSR 92 0.08 0.03 -45 qR in I, aVL, rS in II, III, aVF 
34 68 M 186/150 6 NSR 74 0.08 0.04 -30 qR in I, aVL, rS in II, III, aVF 
35 50 M 190/160 16 NSR 100 0.08 0.03 +20 qR in I, aVL, rS in II, III, aVF 
36 52 M 184/136 9 NSR 94 0.08 0.04 -30 qR in I, aVL, rS in II, III, aVF 
37 58 M 178/154 14 NSR 82 0.08 0.04 +20 qR in I, aVL, rS in II, III, aVF 
38 49 M 186/150 11 NSR 70 0.08 0.04 +55 qR in I, aVL, rS in II, III, aVF 
39 72 M 196/154 10 NSR 86 0.07 0.04 +15 qR in I, aVL, rS in II, III, aVF 
40 55 F 200/160 6 NSR 82 0.08 0.04 -15 qR in I, aVL, rS in II, III, aVF 
41 56 M 194/166 8 NSR 80 0.08 0.03 -45 qR in I, aVL, rS in II, III, aVF 
42 65 M 182/142 9 NSR 84 0.08 0.03 -10 qR in I, aVL, rS in II, III, aVF 
43 48 M 168/140 13 NSR 78 0.07 0.04 -45 qR in I, aVL, rS in II, III, aVF 
44 57 M 188/150 18 NSR 74 0.08 0.03 +60 qR in I, aVL, rS in II, III, aVF 
45 68 M 212/146 9 NSR 106 0.07 0.04 -30 qR in I, aVL, rS in II, III, aVF 
46 69 F 196/160 10 NSR 86 0.08 0.03 +65 qR in I, aVL, rS in II, III, aVF 
47 65 M 202/158 19 NSR 90 0.08 0.04 +40 qR in I, aVL, rS in II, III, aVF 
48 64 M 166/124 16 NSR 70 0.08 0.03 -45 qR in I, aVL, rS in II, III, aVF 
49 63 M 186/142 12 NSR 94 0.07 0.04 +15 qR in I, aVL, rS in II, III, aVF 
50 60 M 196/134 17 NSR 82 0.08 0.03 -35 qR in I, aVL, rS in II, III, aVF 
51 61 M 180/144 10 NSR 104 0.08 0.04 +15 qR in I, aVL, rS in II, III, aVF 
52 64 M 188/138 15 NSR 92 0.08 0.04 -30 qR in I, aVL, rS in II, III, aVF 
53 61 F 204/164 6 NSR 78 0.08 0.03 +20 qR in I, aVL, rS in II, III, aVF 
54 59 M 196/144 4 NSR 94 0.08 0.04 +45 qR in I, aVL, rS in II, III, aVF 
55 72 M 190/160 10 NSR 72 0.08 0.03 -30 qR in I, aVL, rS in II, III, aVF 
56 68 M 176/132 5 NSR 78 0.08 0.04 -45 qR in I, aVL, rS in II, III, aVF 
C.NO AGE SEX B.P NO of yearsof 
Hypertension 
RHYTHM RATE QRS VAT QRS 
Axis 
QRS Configuration 
57 60 M 188/146 6 NSR 76 0.08 0.03 +55 qR in I, aVL, rS in II, III, aVF 
58 61 M 206/168 5 NSR 80 0.07 0.04 +20 qR in I, aVL, rS in II, III, aVF 
59 63 M 210/168 8 NSR 92 0.08 0.03 +60 RR in VI V2 wides in V5 V6 I aVL 
60 59 F 204/180 9 NSR 72 0.08 0.04 +10 rSR in V1 V2wide sin I V5 V6 
61 58 M 198/178 12 NSR 68 0.08 0.03 +15 rSR in  V1wide s  in I II V456 
62 60 M 180/140 17 NSR 72 0.07 0.04 -15 RR  in VI V2   wide  s in V5 V6 I aVL 
63 69 M 178/144 8 NSR 70 0.08 0.03 +45 rSR  in V1 V2  wide  s in I V5 V6 
64 52 F 194/148 3 NSR 104 0.08 0.04 +5 rSR in V1  wide s in I  II  V456 
65 70 F 176/146 6 NSR 86 0.08 0.03 +40 rSR  in V1 V2  wide s  in I V5 V6 
66 54 M 210/166 11 NSR 82 0.08 0.04 -30 RR   in VI V2 wide s in V5 V6 I  aVL 
67 62 M 202/166 18 NSR 76 0.08 0.04 +65 rSR in V1 V2  wide s  in I V5 V6 
68 49 M 168/138 10 NSR 88 0.08 0.03 +40 rSR in V1 V2  wide s  in I V5 V6 
69 65 M 194/156 8 NSR 72 0.08 0.04 -25 RR in VI V2 wide s  in V5 V6 I aVL 
70 57 M 208/166 9 NSR 70 0.08 0.04 +15 rSR in V1 V2wide sin I V5 V6 
71 45 M 164/128 4 NSR 92 0.07 0.04 +45 rSR in V1 V2wide sin I V5 V6 
72 72 M 180/150 16 NSR 84 0.08 0.03 +60 RR  in VI V2  wide s in V5 V6 I aVL 
73 64 F 186/148 6 NSR 78 0.08 0.04 +20 Slurred R in V5,V6 wide  s inV1 
74 60 M 210/168 3 NSR 70 0.08 0.04 +35 RR in V6 wide s in V1,V2 
75 59 M 188/160 7 NSR 82 0.08 0.03 +30 M pattern in V5,V6 wide s in VI 
76 52 M 166/138 10 NSR 80 0.08 0.04 -45 Slurred R in V5,V6 wide s inV1 
77 59 F 192/164 3 NSR 70 0.08 0.04 -30 RR in V6 wide s in V1,V2 
78 66 M 212/168 16 NSR 88 0.08 0.04 -60 Slurred R in V5,V6 wide s inV1 
79 50 M 174/146 12 NSR 74 0.08 0.03 +65 RR in V6 wide s in V1,V2 
80 48 M 190/144 5 NSR 92 0.08 0.04 +35 M pattern in V5,V6 wide s in VI 
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